Clinical trial

A Study of the Safety and Efficacy of Combination Therapy With Morphine…

NCT00374881 · BioLineRx, Ltd., Industry · Completed

Key facts

NCT number NCT00374881
Title A Study of the Safety and Efficacy of Combination Therapy With Morphine, Phenylephrine and Sorbitol in Human Subjects
Official title A Randomized, Double-Blind, Single-Center, 5 Way Cross-Over Study to Assess the Effect of Adding Oral Phenylephrine and Oral Sorbitol to Low Dose (1.5 mg) Plain Oral Morphine in Human Volunteers: Analgesia and Side Effect Assessment.
Lead sponsor BioLineRx, Ltd., Industry
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Acute Pain
Intervention type Drug
Interventions Morphine, Sorbitol+Phenylephrine, Sorbitol+Phenylephrine+Morphine, Sorbitol low concentration+Phenylephrine+Morphine
Enrollment 9
Start date Sep 1, 2006
Primary completion Jun 1, 2007
Completion Aug 1, 2007
First posted Sep 12, 2006
Last update posted Apr 15, 2008
Countries Israel

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies